Cargando…

The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans

β-Mannans are plant cell wall polysaccharides that are commonly found in human diets. However, a mechanistic understanding into the key populations that degrade this glycan is absent, especially for the dominant Firmicutes phylum. Here, we show that the prominent butyrate-producing Firmicute Rosebur...

Descripción completa

Detalles Bibliográficos
Autores principales: La Rosa, Sabina Leanti, Leth, Maria Louise, Michalak, Leszek, Hansen, Morten Ejby, Pudlo, Nicholas A., Glowacki, Robert, Pereira, Gabriel, Workman, Christopher T., Arntzen, Magnus Ø., Pope, Phillip B., Martens, Eric C., Hachem, Maher Abou, Westereng, Bjørge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385246/
https://www.ncbi.nlm.nih.gov/pubmed/30796211
http://dx.doi.org/10.1038/s41467-019-08812-y
Descripción
Sumario:β-Mannans are plant cell wall polysaccharides that are commonly found in human diets. However, a mechanistic understanding into the key populations that degrade this glycan is absent, especially for the dominant Firmicutes phylum. Here, we show that the prominent butyrate-producing Firmicute Roseburia intestinalis expresses two loci conferring metabolism of β-mannans. We combine multi-“omic” analyses and detailed biochemical studies to comprehensively characterize loci-encoded proteins that are involved in β-mannan capturing, importation, de-branching and degradation into monosaccharides. In mixed cultures, R. intestinalis shares the available β-mannan with Bacteroides ovatus, demonstrating that the apparatus allows coexistence in a competitive environment. In murine experiments, β-mannan selectively promotes beneficial gut bacteria, exemplified by increased R. intestinalis, and reduction of mucus-degraders. Our findings highlight that R. intestinalis is a primary degrader of this dietary fiber and that this metabolic capacity could be exploited to selectively promote key members of the healthy microbiota using β-mannan-based therapeutic interventions.